Inhalable Formulation Based on Lipid–Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast-Reference-Cited by-同舟云学术

Inhalable Formulation Based on Lipid–Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast

Published:2022-07-28 Issue:8 Volume:23 Page:3439-3451
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Craparo Emanuela F.¹²,Cabibbo Marta¹,Scialabba Cinzia¹,Giammona Gaetano¹²,Cavallaro Gennara¹²³^ORCID

Affiliation:

1. Lab of Biocompatible Polymers, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, Palermo90123, Italy

2. Consorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali (INSTM) of Palermo, Palermo, Italy

3. Advanced Technology and Network Center (ATeN Center), Università di Palermo, Palermo90133, Italy

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.2c00576

Reference38 articles.

1. Engineering precision nanoparticles for drug delivery

Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives

3. Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications

4. Phosphodiesterases as therapeutic targets for respiratory diseases

5. The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of nano- and micro-particle-based approaches for selected bronchodilators in management of asthma;3 Biotech;2024-08-23

2. Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation;Nanomedicine;2024-08-15

3. Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization;Pharmaceutics;2024-08-12

4. Nanostructured Hybrid Polymer‐Lipid Drug Delivery Platforms for Rapamycin Repositioning in Anticancer Therapy;Advanced Therapeutics;2024-08-07

5. Lung Disease Management by Iloprost-Loaded Nanoparticles to Address Hyperinflammation Associated with Cystic Fibrosis;ACS Applied Nano Materials;2024-06-11